Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Starting an Advanced Practice Provider Practice

Client Alert

Advanced practice providers (APPs), which includes non-physician providers such as nurse practitioners, physician assistants, and nurse anesthetists, commonly start their own healthcare practices. Practices may provide, for example, service offerings such as primary care, anesthesiology, mental health, and aesthetics (medical spas). However, there are a number of considerations and steps that must be taken for APPs to compliantly function independently.

First and foremost, the state where the APP will be operating their practice dictates whether an APP can even open a practice independently. Key considerations include the following:

  1. State Scope of Practice Laws: Can the provider practice independently in the state, or is another provider, such as a physician required to be on-site? Are the services within the APP’s scope of practice, as dictated by state law? For example, in Ohio, nurse practitioners are required to have a standard care arrangement with a collaborating physician and must practice in accordance with their education, clinical experience, and national certification. CRNAs, for example, may be required to practice under their RN license if they wish to provide aesthetic services.
  2. State Corporate Practice of Medicine: Can an APP operate a healthcare practice in the state, or is it limited to physicians? Other considerations here include who the APP can hire at their practice, as some states, for example, do not let providers hire providers with “higher” licenses (i.e., an APP cannot hire a physician).

Once it is determined that an APP is permitted to open an independent practice, the APP will need to file their business in accordance with applicable state filing laws, typically dictated by the applicable state’s Secretary of State. For example, the practice may need to file as a professional entity rather than a regular business corporation or limited liability company. The practice will also need an employee identification number (EIN) in order to hire employees. Additionally, with the enactment of the Corporate Transparency Act, businesses may be required to submit a Beneficial Ownership Information (BOI) Report to the U.S. Department of Treasury’s Financial Crimes Enforcement Network (FinCEN).

Further, APPs should determine how they want to be paid, whether it be cash-pay, through insurance, or both. What is best for the practice will largely depend on the kinds of services being offered. If the APP determines they do want to accept insurance, they will need to complete the appropriate credentialing and application process for different payors. If the practice is a covered entity under the Health Insurance Portability and Accountability Act (HIPAA), it will also need a National Provider Identifier (NPI).

Lastly, the practice will need to obtain a site-specific Drug Enforcement Agency (DEA) registration and/or terminal distributor of dangerous drugs (TDDD) license if the APP plans to prescribe controlled substances and/or dangerous drugs (prescription medications), unless the practice meets an exception for such licensure.

If you have any questions about any of the above information,  or any other questions related to starting your own practice, please don’t hesitate to contact BMD Health Law Group Member Jeana M. Singleton at jmsingleton@bmdllc.com or 330-253-2001, or BMD Attorney Rachel Stermer at rcstermer@bmdllc.com or 330-253-2019.  


Five Common Pitfalls for Employers to Watch Out for Under the Fair Labor Standards Act

The Fair Labor Standards Act (FLSA) sets forth requirements for employers including, but not limited to, minimum wage, overtime pay, and recordkeeping for covered employees. These requirements are not as simple as they may appear on their face, which leads many employers to fall into compliance issues that they did not realize even existed.

The NLRB Limits the Reach of Confidentiality and Non-Disparagement Provisions in Severance Agreements Overruling Trump-Era Policies

Employers should exercise caution and closely examine the content of severance agreements to ensure compliance with a recent National Labor Relations Board (“NLRB”) decision.  On February 21, 2023, the NLRB restricted the breadth of permissible language of confidentiality and non-disparagement clauses when it issued its decision in McLaren Macomb and overruled its Trump-era decisions in Baylor University Medical Center and IGT d/b/a International Game Technology.

Ohio Medical Board Releases New Telehealth Rules

On Tuesday, February 21, 2023, the State Medical Board of Ohio released its final telehealth rules to implement Ohio’s telehealth statute (O.R.C. 4743.09) for physicians, physician assistants, dieticians, respiratory care professionals and genetic counselors. Ohio’s advanced practice registered nurses (“APRNs”) should also take note of these rules. While the Medical Board does not govern APRNs directly, those APRNs who are required to have a collaborating physician and standard care arrangement (namely nurse practitioners, certified nurse midwives, and clinical nurse specialists) are still affected by the rules. Generally, if an APRN’s collaborating physician is limited in their practice, then the APRN will also be limited.

The End of the Public Health Emergency is (Finally) Here

The COVID-19 Public Health Emergency (“PHE”) that has been in effect for over three years is finally slated to end on May 11, 2023.[1] With the end of the PHE will come many changes for healthcare providers to be aware of; however, some changes may not come until much later.

Multi-340B Contract Pharmacy Locations on the Brink? The Third Circuit’s Ruling Gives a Hint.

The 340B drug discount program requires pharmaceutical manufacturers to offer to sell their products at significant discounts to safety net providers called “covered entities.” In 1996, the Health Resources and Services Administration (HRSA) issued guidance authorizing covered entities to enter into a contract pharmacy arrangement with a single third-party contract pharmacy, to which the manufacturer would ship 340B medications but bill the covered entity. In 2010, HRSA issued revised guidance permitting covered entities to enter into an unlimited number of contract pharmacy arrangements.